163 related articles for article (PubMed ID: 38334907)
21. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
[TBL] [Abstract][Full Text] [Related]
22. The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.
D'Amico RS; Cloney MB; Sonabend AM; Zacharia B; Nazarian MN; Iwamoto FM; Sisti MB; Bruce JN; McKhann GM
World Neurosurg; 2015 Oct; 84(4):913-9. PubMed ID: 26074434
[TBL] [Abstract][Full Text] [Related]
23. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
24. ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.
Kim N; Kim SH; Kang SG; Moon JH; Cho J; Suh CO; In Yoon H; Chang JH
Radiat Oncol; 2020 Jul; 15(1):184. PubMed ID: 32736562
[TBL] [Abstract][Full Text] [Related]
25. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
[TBL] [Abstract][Full Text] [Related]
26. Using cortical function mapping by awake craniotomy dealing with the patient with recurrent glioma in the eloquent cortex.
Li YC; Chiu HY; Wei KC; Lin YJ; Chen KT; Hsu PW; Huang YC; Chen PY
Biomed J; 2021 Dec; 44(6 Suppl 1):S48-S53. PubMed ID: 35735084
[TBL] [Abstract][Full Text] [Related]
27. The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Aghi MK; Nahed BV; Sloan AE; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):503-30. PubMed ID: 26530265
[TBL] [Abstract][Full Text] [Related]
28. Resection and reoperation in neuro-oncology. Rationale and approach.
Salcman M
Neurol Clin; 1985 Nov; 3(4):831-42. PubMed ID: 3908898
[TBL] [Abstract][Full Text] [Related]
29. Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort.
Dao Trong P; Gluszak M; Reuss D; von Deimling A; Wick A; König L; Debus J; Herold-Mende C; Unterberg A; Jungk C
J Neurooncol; 2023 Feb; 161(3):605-615. PubMed ID: 36648586
[TBL] [Abstract][Full Text] [Related]
30. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
[TBL] [Abstract][Full Text] [Related]
31. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
[TBL] [Abstract][Full Text] [Related]
32. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
[TBL] [Abstract][Full Text] [Related]
33. Perioperative outcomes following reoperation for recurrent insular gliomas.
Morshed RA; Young JS; Han SJ; Hervey-Jumper SL; Berger MS
J Neurosurg; 2018 Sep; 131(2):467-473. PubMed ID: 30239317
[TBL] [Abstract][Full Text] [Related]
34. Reoperation for recurrent high-grade glioma: a current perspective of the literature.
Hervey-Jumper SL; Berger MS
Neurosurgery; 2014 Nov; 75(5):491-9; discussion 498-9. PubMed ID: 24991712
[TBL] [Abstract][Full Text] [Related]
35. Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.
Familiari P; Lapolla P; Picotti V; Palmieri M; Pesce A; Carosi G; Relucenti M; Nottola S; Gianno F; Minasi S; Antonelli M; Frati A; Santoro A; D'Andrea G; Bruzzaniti P; LA Pira B
Anticancer Res; 2023 Jun; 43(6):2659-2670. PubMed ID: 37247932
[TBL] [Abstract][Full Text] [Related]
36. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
[TBL] [Abstract][Full Text] [Related]
37. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
Muzyka L; Goff NK; Choudhary N; Koltz MT
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
39. Distinct metabolic hallmarks of WHO classified adult glioma subtypes.
Björkblom B; Wibom C; Eriksson M; Bergenheim AT; Sjöberg RL; Jonsson P; Brännström T; Antti H; Sandström M; Melin B
Neuro Oncol; 2022 Sep; 24(9):1454-1468. PubMed ID: 35157758
[TBL] [Abstract][Full Text] [Related]
40. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
